Literature DB >> 20956554

Cyclin D3 is selectively required for proliferative expansion of germinal center B cells.

Matthew H Cato1, Suresh K Chintalapati, Irene W Yau, Sidne A Omori, Robert C Rickert.   

Abstract

The generation of robust T-cell-dependent humoral immune responses requires the formation and expansion of germinal center structures within the follicular regions of the secondary lymphoid tissues. B-cell proliferation in the germinal center drives ongoing antigen-dependent selection and the generation of high-affinity class-switched plasma and memory B cells. However, the mechanisms regulating B-cell proliferation within this microenvironment are largely unknown. Here, we report that cyclin D3 is uniquely required for germinal center progression. Ccnd3(-/-) mice exhibit a B-cell-intrinsic defect in germinal center maturation and fail to generate an affinity-matured IgG response. We determined that the defect resulted from failed proliferative expansion of GL7(+) IgD(-) PNA(+) B cells. Mechanistically, sustained expression of cyclin D3 was found to be regulated at the level of protein stability and controlled by glycogen synthase kinase 3 in a cyclic AMP-protein kinase A-dependent manner. The specific defect in proliferative expansion of GL7(+) IgD(-) PNA(+) B cells in Ccnd3(-/-) mice defines an underappreciated step in germinal center progression and solidifies a role for cyclin D3 in the immune response, and as a potential therapeutic target for germinal center-derived B-cell malignancies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956554      PMCID: PMC3019862          DOI: 10.1128/MCB.00650-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

Authors:  M Sánchez-Beato; F I Camacho; J C Martínez-Montero; A I Sáez; R Villuendas; L Sánchez-Verde; J F García; M A Piris
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

2.  Expression of cyclin D2 and D3 in lymphoid lesions.

Authors:  N Teramoto; K Pokrovskaja; L Szekely; A Polack; T Yoshino; T Akagi; G Klein
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

3.  CD19 regulates B cell maturation, proliferation, and positive selection in the FDC zone of murine splenic germinal centers.

Authors:  Yue Wang; Robert H Carter
Journal:  Immunity       Date:  2005-06       Impact factor: 31.745

4.  The regulated expression of cell cycle-related proteins as B-lymphocytes enter and progress through the G1 cell cycle stage following delivery of complete versus partial activation stimuli.

Authors:  S Reid; E C Snow
Journal:  Mol Immunol       Date:  1996-10       Impact factor: 4.407

5.  Switch recombination and germ-line transcription are division-regulated events in B lymphocytes.

Authors:  M N McCall; P D Hodgkin
Journal:  Biochim Biophys Acta       Date:  1999-10-06

6.  The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.

Authors:  Uttiya Basu; Jayanta Chaudhuri; Craig Alpert; Shilpee Dutt; Sheila Ranganath; Gang Li; Jason Patrick Schrum; John P Manis; Frederick W Alt
Journal:  Nature       Date:  2005-10-26       Impact factor: 49.962

7.  PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells.

Authors:  Laura Pasqualucci; Yasuyuki Kitaura; Hua Gu; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-30       Impact factor: 11.205

8.  Selective usage of D-type cyclins in lymphoid malignancies.

Authors:  R Suzuki; H Kuroda; H Komatsu; Y Hosokawa; Y Kagami; M Ogura; S Nakamura; Y Kodera; Y Morishima; R Ueda; M Seto
Journal:  Leukemia       Date:  1999-09       Impact factor: 11.528

9.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization.

Authors:  J A Diehl; M Cheng; M F Roussel; C J Sherr
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

10.  Germinal center founder cells display propensity for apoptosis before onset of somatic mutation.

Authors:  S Lebecque; O de Bouteiller; C Arpin; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more
  48 in total

1.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

2.  Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer Cells.

Authors:  Timothy J Zumwalt; Dominik Wodarz; Natalia L Komarova; Shusuke Toden; Jacob Turner; Jacob Cardenas; John Burn; Andrew T Chan; C Richard Boland; Ajay Goel
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-02

3.  Mediator subunit MED1 is required for E2A-PBX1-mediated oncogenic transcription and leukemic cell growth.

Authors:  Yu-Ling Lee; Keiichi Ito; Wen-Chieh Pi; I-Hsuan Lin; Chi-Shuen Chu; Sohail Malik; I-Hsin Cheng; Wei-Yi Chen; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-09       Impact factor: 11.205

4.  Magnetic-based purification of untouched mouse germinal center B cells for ex vivo manipulation and biochemical analysis.

Authors:  Matthew H Cato; Irene W Yau; Robert C Rickert
Journal:  Nat Protoc       Date:  2011-06-09       Impact factor: 13.491

5.  Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.

Authors:  Stefano Monti; Bjoern Chapuy; Kunihiko Takeyama; Scott J Rodig; Yansheng Hao; Kelly T Yeda; Haig Inguilizian; Craig Mermel; Treeve Currie; Ahmet Dogan; Jeffery L Kutok; Rameen Beroukhim; Donna Neuberg; Thomas M Habermann; Gad Getz; Andrew L Kung; Todd R Golub; Margaret A Shipp
Journal:  Cancer Cell       Date:  2012-09-11       Impact factor: 31.743

6.  Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.

Authors:  Alyssa Bouska; Chengfeng Bi; Waseem Lone; Weiwei Zhang; Ambreen Kedwaii; Tayla Heavican; Cynthia M Lachel; Jiayu Yu; Roberto Ferro; Nanees Eldorghamy; Timothy C Greiner; Julie Vose; Dennis D Weisenburger; Randy D Gascoyne; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Elaine S Jaffe; Rita M Braziel; Reiner Siebert; Rodney R Miles; Sandeep Dave; Anupama Reddy; Jan Delabie; Louis M Staudt; Joo Y Song; Timothy W McKeithan; Kai Fu; Michael Green; Wing C Chan; Javeed Iqbal
Journal:  Blood       Date:  2017-08-11       Impact factor: 22.113

Review 7.  The PI3K pathway in B cell metabolism.

Authors:  Julia Jellusova; Robert C Rickert
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-08-05       Impact factor: 8.250

8.  Lymphocyte lineage-specific and developmental stage specific mechanisms suppress cyclin D3 expression in response to DNA double strand breaks.

Authors:  Amy DeMicco; Tyler Reich; Rahul Arya; Adrian Rivera-Reyes; Megan R Fisher; Craig H Bassing
Journal:  Cell Cycle       Date:  2016-06-21       Impact factor: 4.534

9.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

10.  B Cell-Intrinsic Expression of the HuR RNA-Binding Protein Is Required for the T Cell-Dependent Immune Response In Vivo.

Authors:  Amy DeMicco; Martin S Naradikian; Vishal J Sindhava; Je-Hyun Yoon; Myriam Gorospe; Gerald B Wertheim; Michael P Cancro; Craig H Bassing
Journal:  J Immunol       Date:  2015-08-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.